1-11 of 11
Yoshihiko Maehara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic and Therapeutic Implications of Aromatase Expression in Lung Adenocarcinomas with EGFR Mutations

Mikihiro Kohno, Tatsuro Okamoto, Kenichi Suda, Mototsugu Shimokawa, Hirokazu Kitahara, Shinichiro Shimamatsu, Hideyuki Konishi, Tsukihisa Yoshida, Mitsuhiro Takenoyama, Tokujiro Yano, Yoshihiko Maehara
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (13): 3613–3622.
https://doi.org/10.1158/1078-0432.CCR-13-2683
Published: 30 June 2014
View article titled, Prognostic and Therapeutic Implications of Aromatase Expression in Lung Adenocarcinomas with <em>EGFR</em> Mutations
Open the PDF for Prognostic and Therapeutic Implications of Aromatase Expression in Lung Adenocarcinomas with <em>EGFR</em> Mutations in another window
Includes: Supplementary data
Journal Articles

Copy-Neutral Loss of Heterozygosity at the p53 Locus in Carcinogenesis of Esophageal Squamous Cell Carcinomas Associated with p53 Mutations

Hiroshi Saeki, Hiroyuki Kitao, Keiji Yoshinaga, Tomonori Nakanoko, Nobuhide Kubo, Yoshihiro Kakeji, Masaru Morita, Yoshihiko Maehara
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 1731–1740.
https://doi.org/10.1158/1078-0432.CCR-10-1996
Published: 31 March 2011
View article titled, Copy-Neutral Loss of Heterozygosity at the <em>p53</em> Locus in Carcinogenesis of Esophageal Squamous Cell Carcinomas Associated with <em>p53</em> Mutations
Open the PDF for Copy-Neutral Loss of Heterozygosity at the <em>p53</em> Locus in Carcinogenesis of Esophageal Squamous Cell Carcinomas Associated with <em>p53</em> Mutations in another window
Journal Articles

Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer

Kenichi Suda, Isao Murakami, Tatsuya Katayama, Kenji Tomizawa, Hirotaka Osada, Yoshitaka Sekido, Yoshihiko Maehara, Yasushi Yatabe, Tetsuya Mitsudomi
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (22): 5489–5498.
https://doi.org/10.1158/1078-0432.CCR-10-1371
Published: 14 November 2010
View article titled, Reciprocal and Complementary Role of <em>MET</em> Amplification and <em>EGFR </em>T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer
Open the PDF for Reciprocal and Complementary Role of <em>MET</em> Amplification and <em>EGFR </em>T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Overexpression of Hypoxia-Inducible Factor 1α and p53 Is a Marker for an Unfavorable Prognosis in Gastric Cancer

Yasushi Sumiyoshi, Yoshihiro Kakeji, Akinori Egashira, Ken Mizokami, Hiroyuki Orita, Yoshihiko Maehara
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (17): 5112–5117.
https://doi.org/10.1158/1078-0432.CCR-05-2382
Published: 01 September 2006
View article titled, Overexpression of Hypoxia-Inducible Factor 1α and p53 Is a Marker for an Unfavorable Prognosis in Gastric Cancer
Open the PDF for Overexpression of Hypoxia-Inducible Factor 1α and p53 Is a Marker for an Unfavorable Prognosis in Gastric Cancer in another window
Journal Articles

Clinical Significance of Heparin-Binding Epidermal Growth Factor–Like Growth Factor and A Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer

Yoshihiro Tanaka, Shingo Miyamoto, Satoshi O. Suzuki, Eiji Oki, Hiroshi Yagi, Kenzo Sonoda, Ayano Yamazaki, Hiroto Mizushima, Yoshihiko Maehara, Eisuke Mekada, Hitoo Nakano
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (13): 4783–4792.
https://doi.org/10.1158/1078-0432.CCR-04-1426
Published: 06 July 2005
View article titled, Clinical Significance of Heparin-Binding Epidermal Growth Factor–Like Growth Factor and A Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer
Open the PDF for Clinical Significance of Heparin-Binding Epidermal Growth Factor–Like Growth Factor and A Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer in another window
Journal Articles

Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma

Shinji Itoh, Takashi Maeda, Mitsuo Shimada, Shin-ichi Aishima, Ken Shirabe, Shinji Tanaka, Yoshihiko Maehara
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (8): 2812–2817.
https://doi.org/10.1158/1078-0432.CCR-1046-03
Published: 20 April 2004
View article titled, Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma
Open the PDF for Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma in another window
Journal Articles

Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma

Yasunori Shikada, Ichiro Yoshino, Tatsuro Okamoto, Seiichi Fukuyama, Toshifumi Kameyama, Yoshihiko Maehara
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5282–5286.
Published: 12 November 2003
View article titled, Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma
Open the PDF for Higher Expression of RhoC Is Related to Invasiveness in Non-Small Cell Lung Carcinoma in another window
Journal Articles

Nuclear Expression of the Y-Box Binding Protein, YB-1, as a Novel Marker of Disease Progression in Non-Small Cell Lung Cancer

Kotaro Shibahara, Kenji Sugio, Toshihiro Osaki, Takeshi Uchiumi, Yoshihiko Maehara, Kimitoshi Kohno, Kosei Yasumoto, Keizo Sugimachi, Michihiko Kuwano
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (10): 3151–3155.
Published: 01 October 2001
View article titled, Nuclear Expression of the Y-Box Binding Protein, YB-1, as a Novel Marker of Disease Progression in Non-Small Cell Lung Cancer
Open the PDF for Nuclear Expression of the Y-Box Binding Protein, YB-1, as a Novel Marker of Disease Progression in Non-Small Cell Lung Cancer in another window
Journal Articles

Clinicopathological Features and Overexpression of Matrix Metalloproteinases in Intramucosal Gastric Carcinoma with Lymph Node Metastasis

Akira Kabashima, Yoshihiko Maehara, Yoshihiro Kakeji, Hideo Baba, Tadashi Koga, Keizo Sugimachi
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (9): 3581–3584.
Published: 01 September 2000
View article titled, Clinicopathological Features and Overexpression of Matrix Metalloproteinases in Intramucosal Gastric Carcinoma with Lymph Node Metastasis
Open the PDF for Clinicopathological Features and Overexpression of Matrix Metalloproteinases in Intramucosal Gastric Carcinoma with Lymph Node Metastasis in another window
Journal Articles

Increased Expression of an ATP-binding Cassette Superfamily Transporter, Multidrug Resistance Protein 2, in Human Colorectal Carcinomas

Eiji Hinoshita, Takeshi Uchiumi, Ken-ichi Taguchi, Naoko Kinukawa, Masazumi Tsuneyoshi, Yoshihiko Maehara, Keizo Sugimachi, Michihiko Kuwano
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2401–2407.
Published: 01 June 2000
View article titled, Increased Expression of an ATP-binding Cassette Superfamily Transporter, Multidrug Resistance Protein 2, in Human Colorectal Carcinomas
Open the PDF for Increased Expression of an ATP-binding Cassette Superfamily Transporter, Multidrug Resistance Protein 2, in Human Colorectal Carcinomas in another window
Journal Articles

MST-16, a Novel Bis-dioxopiperazine Anticancer Agent, Ameliorates Doxorubicin-induced Acute Toxicity While Maintaining Antitumor Efficacy

Motofumi Yoshida, Yoshihiko Maehara, Keizo Sugimachi
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4295–4300.
Published: 01 December 1999
View article titled, MST-16, a Novel Bis-dioxopiperazine Anticancer Agent, Ameliorates Doxorubicin-induced Acute Toxicity While Maintaining Antitumor Efficacy
Open the PDF for MST-16, a Novel Bis-dioxopiperazine Anticancer Agent, Ameliorates Doxorubicin-induced Acute Toxicity While Maintaining Antitumor Efficacy in another window